Anurag Singh, MD, shares new research indicating that non-small cell lung cancer (NSCLC) patients may benefit from a single dose of stereotactic body radiation therapy (SBRT) as much as they would from three separate SBRT treatments. Read more: https://goo.gl/3I4mxf
NSCLC Patients May Benefit From Single Dose of SBRT
